TY - JOUR
T1 - Concurrent Eosinophilia Increases the Prevalence of Nail Abnormalities and Severity of Hair Loss in Patients with Alopecia Areata
AU - Damiani, Giovanni
AU - Gironi, Laura Cristina
AU - Conic, Rosalynn R.Z.
AU - Del Fabbro, Massimo
AU - Savoia, Paola
AU - Fiore, Marco
AU - Bergfeld, Wilma F.
N1 - Publisher Copyright:
© 2024 Giovanni Damiani et al.
PY - 2024
Y1 - 2024
N2 - Background: The potential link between alopecia areata (AA) and eosinophilia is unclear, as well as its clinical manifestations in these patients' subsets.Methods: This is a monocentric retrospective observational study in which clinical and laboratory data were summarized and evaluated the AA subset with concurrent eosinophilia.Results: In a sample of 205 AA patients, 38 (18.5%) were classified as AA with eosinophilia. Interestingly, this subset of patients had a statistically higher prevalence of atopia and nail abnormalities (p<0.05) than AA without eosinophilia. AA patients with eosinophilia had a 3.70 higher odds of more severe hair loss versus age- and gender-matched AA without eosinophilia.Conclusions: AA patients with eosinophilia had distinctive clinical and laboratory characteristics, so future studies may potentially explore the use of IL-5 inhibitors.
AB - Background: The potential link between alopecia areata (AA) and eosinophilia is unclear, as well as its clinical manifestations in these patients' subsets.Methods: This is a monocentric retrospective observational study in which clinical and laboratory data were summarized and evaluated the AA subset with concurrent eosinophilia.Results: In a sample of 205 AA patients, 38 (18.5%) were classified as AA with eosinophilia. Interestingly, this subset of patients had a statistically higher prevalence of atopia and nail abnormalities (p<0.05) than AA without eosinophilia. AA patients with eosinophilia had a 3.70 higher odds of more severe hair loss versus age- and gender-matched AA without eosinophilia.Conclusions: AA patients with eosinophilia had distinctive clinical and laboratory characteristics, so future studies may potentially explore the use of IL-5 inhibitors.
UR - https://www.scopus.com/pages/publications/85204418141
U2 - 10.1155/2024/5596647
DO - 10.1155/2024/5596647
M3 - Article
SN - 2314-6133
VL - 2024
JO - BioMed Research International
JF - BioMed Research International
M1 - 5596647
ER -